Jubbonti Interactions
There are 312 drugs known to interact with Jubbonti (denosumab), along with 2 disease interactions. Of the total drug interactions, 5 are major, and 307 are moderate.
- View all 312 medications that may interact with Jubbonti
- View Jubbonti disease interactions (2)
Most frequently checked interactions
View interaction reports for Jubbonti (denosumab) and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- alpha-lipoic acid
- amlodipine
- B Complex 100 (multivitamin)
- biotin
- calcium citrate
- candesartan
- cannabis
- citicoline
- clotrimazole topical
- Coenzyme Q10 (ubiquinone)
- dexlansoprazole
- doxepin
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- folic acid
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- iron bisglycinate
- Melatonin Time Release (melatonin)
- milk thistle
- PreserVision AREDS 2 (multivitamin with minerals)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Simlandi (adalimumab)
- thiamine
- trazodone
- turmeric
- Tyenne (tocilizumab)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zinc (zinc sulfate)
Jubbonti disease interactions
There are 2 disease interactions with Jubbonti (denosumab) which include:
More about Jubbonti (denosumab)
- Jubbonti consumer information
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.